Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QMF149 vs mometasone in uncontrolled asthma
CTR20160632Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atectura breezhaler in asthma, sponsored by Novartis. Started Dec 2016; status: completed.
02
Drugs
atectura breezhaler
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20160632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160632.